The psychedelic renaissance: can psilocybin possibly combat depression?
Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh
International Journal of Surgery Global Health November 1, 2022 DOI: 10.1097/gh9.0000000000000089 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Anxiety Depression Psilocybin |
| Keywords | Mental health Depression economics Population Psychological intervention Clinical psychology Hallucinogen Mood |
| Key points | The text states that the COVID-19 pandemic increased major depressive disorder cases by 27.6% and anxiety disorder cases by 25.6%, with an estimated 137.1 and 116.1 additional disability-adjusted life years per 100,000 population, respectively, attributed to these conditions during the period. |
Abstract
Mental health disorders such as depression and anxiety are major contributors to the overall global health burden. COVID-19 has further aggravated mental health disorders and also increased substance abuse due to lockdowns1. The Global Burden of Disease reported that the pandemic has led to a 27.6% increase in cases of major depressive disorder (MDD) and a 25.6% increase in cases of anxiety disorders2. An estimated 137.1 (95% UI: 92.5–190.6) additional disability-adjusted life years per 100 000 population for MDD and 116.1 per 100,000 population (95% UI: 79.3–163.80) for anxiety disorders have been incurred, as well, during this period3.
Citations in the library
Cites 12
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Long-term follow-up of psilocybin-facilitated smoking cessation The American Journal of Drug and Alcohol Abuse July 21, 2016
- Side-effects associated with ketamine use in depression: a systematic review. The Lancet Psychiatry 2018
and 7 more in the library